In their 2018 study, Yan and colleagues found that a shift in metabolic mediators associated with miRNA-340 contributes to a resulting decrease in GLUT1-mediated glycolysis and a reduction in the proliferation of tumor cells. Here, SLC2A1 is linked to neoplasm.